The safety and effectiveness of divalproex sodium (Depakapote®) in the treatment of 40 children and adolescents, aged 7 to 19 years, with a primary diagnosis of bipolar disorder were evaluated by open-label study (2-8 weeks) at the University of Texas, Galveston; University of Pennsylvania, Philadelphia; SUNY Stonybrook, NY; Massachusetts General Hospital, Boston; and University of Texas, San Antonio.

Millichap, J.G., 0AD. Trial of Divalproex for Bipolar Disorder. Pediatric Neurology Briefs, {volume}({issue}), p.{page}.DOI: https://doi.org/10.15844/pedneurbriefs-16-10-2

Millichap, J G. “Trial of Divalproex for Bipolar Disorder”. Pediatric Neurology Briefs, vol. {volume}, no. {issue}, 0AD, p. {page}.DOI: https://doi.org/10.15844/pedneurbriefs-16-10-2

Millichap, J. G. (0AD). Trial of Divalproex for Bipolar Disorder. Pediatric Neurology Briefs, {volume}({issue}), {page}.DOI: https://doi.org/10.15844/pedneurbriefs-16-10-2

Millichap, J Gordon. 0AD. “Trial of Divalproex for Bipolar Disorder”. Pediatric Neurology Briefs {volume} ({issue}): {page}.DOI: https://doi.org/10.15844/pedneurbriefs-16-10-2

1. Millichap JG. Trial of Divalproex for Bipolar Disorder. Pediatric Neurology Briefs. 0AD;{volume}({issue}):{page}. DOI: https://doi.org/10.15844/pedneurbriefs-16-10-2

1. Millichap JG. Trial of Divalproex for Bipolar Disorder. Pediatric Neurology Briefs. 0AD;{volume}({issue}):{page}.DOI: https://doi.org/10.15844/pedneurbriefs-16-10-2

Millichap JG, ‘Trial of Divalproex for Bipolar Disorder’ (0AD) {volume} Pediatric Neurology Briefs {page}DOI: https://doi.org/10.15844/pedneurbriefs-16-10-2

[1]J. G. Millichap, “Trial of Divalproex for Bipolar Disorder”, Pediatric Neurology Briefs, vol. {volume}, no. {issue}, p. {page}, 0AD.DOI: https://doi.org/10.15844/pedneurbriefs-16-10-2

This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 license (unless stated otherwise) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Attention Deficit Disorders

Trial of Divalproex for Bipolar Disorder

Authors:

Abstract

Keywords: